148 related articles for article (PubMed ID: 11911244)
1. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
[TBL] [Abstract][Full Text] [Related]
2. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
4. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck.
Staibano S; Lo Muzio L; Pannone G; Mezza E; Argenziano G; Vetrani A; Lucariello A; Franco R; Errico ME; De Rosa G;
Am J Clin Pathol; 2001 Jun; 115(6):805-13. PubMed ID: 11392875
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 and p53 expression in stage I endometrial carcinoma.
Giatromanolaki A; Sivridis E; Koukourakis MI; Harris AL; Gatter KC
Anticancer Res; 1998; 18(5B):3689-93. PubMed ID: 9854478
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
8. [Expression of bcl-2, bax and p53 protein in the basal cell carcinoma].
Yan L; Chen M; Yu G
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):179-80. PubMed ID: 11938785
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma.
Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Motoo Y; Okai T; Sawabu N
Br J Cancer; 1999 Jun; 80(7):1075-9. PubMed ID: 10362119
[TBL] [Abstract][Full Text] [Related]
10. [A study on the expression of p16 protein and bcl-2 protein in cutaneous eyelid tumors].
Niu Y; Liu F; Meng X; Wang H; Lin H
Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):259-62, 15. PubMed ID: 11853608
[TBL] [Abstract][Full Text] [Related]
11. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy.
Wilson GD; Grover R; Richman PI; Daley FM; Saunders MI; Dische S
Anticancer Res; 1996; 16(4C):2403-8. PubMed ID: 8816842
[TBL] [Abstract][Full Text] [Related]
14. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
[TBL] [Abstract][Full Text] [Related]
15. p53 protein in aggressive and non-aggressive basal cell carcinoma.
De Rosa G; Staibano S; Barra E; Donofrio V; Salvatore G; Vessecchia G; Boscaino A
J Cutan Pathol; 1993 Oct; 20(5):429-34. PubMed ID: 7507946
[TBL] [Abstract][Full Text] [Related]
16. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy.
Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD
Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081
[TBL] [Abstract][Full Text] [Related]
17. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma.
Uzunlar AK; Sahin H; Yilmaz F; Ozekinci S
Saudi Med J; 2005 Jan; 26(1):37-41. PubMed ID: 15756350
[TBL] [Abstract][Full Text] [Related]
19. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
20. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
You JQ; Wang P
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
